 | • レポートコード：GIR-23F3441 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医療機器 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Gastro Esophageal Reflux Disease Drug and Devices Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の胃食道逆流症治療薬及びデバイスの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 胃食道逆流症治療薬及びデバイス市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・治療薬、デバイス アプリケーション別セグメントは次のように区分されます。 ・薬物治療、外科的治療、低侵襲治療 世界の胃食道逆流症治療薬及びデバイス市場の主要なマーケットプレーヤーは以下のとおりです。 ・Endogastric Solutions、Medigus、Medtronic、Carbon Medical technologies、Johnson & Johnson 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 胃食道逆流症治療薬及びデバイスの概要 - タイプ別分析（2017年vs2021年vs2028年）：治療薬、デバイス - アプリケーション別分析（2017年vs2021年vs2028年）：薬物治療、外科的治療、低侵襲治療 - 世界の胃食道逆流症治療薬及びデバイス市場規模・予測 - 世界の胃食道逆流症治療薬及びデバイス生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Endogastric Solutions、Medigus、Medtronic、Carbon Medical technologies、Johnson & Johnson ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：治療薬、デバイス ・アプリケーション別分析2017年-2028年：薬物治療、外科的治療、低侵襲治療 ・胃食道逆流症治療薬及びデバイスの北米市場分析 - 胃食道逆流症治療薬及びデバイスの北米市場：タイプ別市場規模2017年-2028年 - 胃食道逆流症治療薬及びデバイスの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・胃食道逆流症治療薬及びデバイスのヨーロッパ市場分析 - ：胃食道逆流症治療薬及びデバイスのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：胃食道逆流症治療薬及びデバイスのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・胃食道逆流症治療薬及びデバイスのアジア太平洋市場分析 - 胃食道逆流症治療薬及びデバイスのアジア太平洋市場：タイプ別市場規模2017年-2028年 - 胃食道逆流症治療薬及びデバイスのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・胃食道逆流症治療薬及びデバイスの南米市場分析 - 胃食道逆流症治療薬及びデバイスの南米市場：タイプ別市場規模2017年-2028年 - 胃食道逆流症治療薬及びデバイスの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・胃食道逆流症治療薬及びデバイスの中東・アフリカ市場分析 - 胃食道逆流症治療薬及びデバイスの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 胃食道逆流症治療薬及びデバイスの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Gastro Esophageal Reflux Disease Drug and Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Gastro Esophageal Reflux Disease Drug and Devices market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Drugs Treatment accounting for % of the Gastro Esophageal Reflux Disease Drug and Devices global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Drugs segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Gastro Esophageal Reflux Disease Drug and Devices include Endogastric Solutions, Medigus, Medtronic, Carbon Medical technologies, and Johnson & Johnson, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Gastro Esophageal Reflux Disease Drug and Devices market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Drugs
Devices
Market segment by Application can be divided into
Drugs Treatment
Surgical Treatment
Minimally Invasive Treatment
The key market players for global Gastro Esophageal Reflux Disease Drug and Devices market are listed below:
Endogastric Solutions
Medigus
Medtronic
Carbon Medical technologies
Johnson & Johnson
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastro Esophageal Reflux Disease Drug and Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gastro Esophageal Reflux Disease Drug and Devices, with price, sales, revenue and global market share of Gastro Esophageal Reflux Disease Drug and Devices from 2019 to 2022.
Chapter 3, the Gastro Esophageal Reflux Disease Drug and Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastro Esophageal Reflux Disease Drug and Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Gastro Esophageal Reflux Disease Drug and Devices market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gastro Esophageal Reflux Disease Drug and Devices.
Chapter 13, 14, and 15, to describe Gastro Esophageal Reflux Disease Drug and Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Gastro Esophageal Reflux Disease Drug and Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gastro Esophageal Reflux Disease Drug and Devices Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Drugs
1.2.3 Devices
1.3 Market Analysis by Application
1.3.1 Overview: Global Gastro Esophageal Reflux Disease Drug and Devices Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Drugs Treatment
1.3.3 Surgical Treatment
1.3.4 Minimally Invasive Treatment
1.4 Global Gastro Esophageal Reflux Disease Drug and Devices Market Size & Forecast
1.4.1 Global Gastro Esophageal Reflux Disease Drug and Devices Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Gastro Esophageal Reflux Disease Drug and Devices Sales in Volume (2017-2028)
1.4.3 Global Gastro Esophageal Reflux Disease Drug and Devices Price (2017-2028)
1.5 Global Gastro Esophageal Reflux Disease Drug and Devices Production Capacity Analysis
1.5.1 Global Gastro Esophageal Reflux Disease Drug and Devices Total Production Capacity (2017-2028)
1.5.2 Global Gastro Esophageal Reflux Disease Drug and Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Gastro Esophageal Reflux Disease Drug and Devices Market Drivers
1.6.2 Gastro Esophageal Reflux Disease Drug and Devices Market Restraints
1.6.3 Gastro Esophageal Reflux Disease Drug and Devices Trends Analysis
2 Manufacturers Profiles
2.1 Endogastric Solutions
2.1.1 Endogastric Solutions Details
2.1.2 Endogastric Solutions Major Business
2.1.3 Endogastric Solutions Gastro Esophageal Reflux Disease Drug and Devices Product and Services
2.1.4 Endogastric Solutions Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Medigus
2.2.1 Medigus Details
2.2.2 Medigus Major Business
2.2.3 Medigus Gastro Esophageal Reflux Disease Drug and Devices Product and Services
2.2.4 Medigus Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Medtronic
2.3.1 Medtronic Details
2.3.2 Medtronic Major Business
2.3.3 Medtronic Gastro Esophageal Reflux Disease Drug and Devices Product and Services
2.3.4 Medtronic Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Carbon Medical technologies
2.4.1 Carbon Medical technologies Details
2.4.2 Carbon Medical technologies Major Business
2.4.3 Carbon Medical technologies Gastro Esophageal Reflux Disease Drug and Devices Product and Services
2.4.4 Carbon Medical technologies Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Product and Services
2.5.4 Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Gastro Esophageal Reflux Disease Drug and Devices Breakdown Data by Manufacturer
3.1 Global Gastro Esophageal Reflux Disease Drug and Devices Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Gastro Esophageal Reflux Disease Drug and Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Gastro Esophageal Reflux Disease Drug and Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Gastro Esophageal Reflux Disease Drug and Devices Manufacturer Market Share in 2021
3.4.2 Top 6 Gastro Esophageal Reflux Disease Drug and Devices Manufacturer Market Share in 2021
3.5 Global Gastro Esophageal Reflux Disease Drug and Devices Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Gastro Esophageal Reflux Disease Drug and Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Gastro Esophageal Reflux Disease Drug and Devices Market Size by Region
4.1.1 Global Gastro Esophageal Reflux Disease Drug and Devices Sales in Volume by Region (2017-2028)
4.1.2 Global Gastro Esophageal Reflux Disease Drug and Devices Revenue by Region (2017-2028)
4.2 North America Gastro Esophageal Reflux Disease Drug and Devices Revenue (2017-2028)
4.3 Europe Gastro Esophageal Reflux Disease Drug and Devices Revenue (2017-2028)
4.4 Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Revenue (2017-2028)
4.5 South America Gastro Esophageal Reflux Disease Drug and Devices Revenue (2017-2028)
4.6 Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Gastro Esophageal Reflux Disease Drug and Devices Sales in Volume by Type (2017-2028)
5.2 Global Gastro Esophageal Reflux Disease Drug and Devices Revenue by Type (2017-2028)
5.3 Global Gastro Esophageal Reflux Disease Drug and Devices Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Gastro Esophageal Reflux Disease Drug and Devices Sales in Volume by Application (2017-2028)
6.2 Global Gastro Esophageal Reflux Disease Drug and Devices Revenue by Application (2017-2028)
6.3 Global Gastro Esophageal Reflux Disease Drug and Devices Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Gastro Esophageal Reflux Disease Drug and Devices Sales by Type (2017-2028)
7.2 North America Gastro Esophageal Reflux Disease Drug and Devices Sales by Application (2017-2028)
7.3 North America Gastro Esophageal Reflux Disease Drug and Devices Market Size by Country
7.3.1 North America Gastro Esophageal Reflux Disease Drug and Devices Sales in Volume by Country (2017-2028)
7.3.2 North America Gastro Esophageal Reflux Disease Drug and Devices Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Gastro Esophageal Reflux Disease Drug and Devices Sales by Type (2017-2028)
8.2 Europe Gastro Esophageal Reflux Disease Drug and Devices Sales by Application (2017-2028)
8.3 Europe Gastro Esophageal Reflux Disease Drug and Devices Market Size by Country
8.3.1 Europe Gastro Esophageal Reflux Disease Drug and Devices Sales in Volume by Country (2017-2028)
8.3.2 Europe Gastro Esophageal Reflux Disease Drug and Devices Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Sales by Type (2017-2028)
9.2 Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Sales by Application (2017-2028)
9.3 Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Market Size by Region
9.3.1 Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Gastro Esophageal Reflux Disease Drug and Devices Sales by Type (2017-2028)
10.2 South America Gastro Esophageal Reflux Disease Drug and Devices Sales by Application (2017-2028)
10.3 South America Gastro Esophageal Reflux Disease Drug and Devices Market Size by Country
10.3.1 South America Gastro Esophageal Reflux Disease Drug and Devices Sales in Volume by Country (2017-2028)
10.3.2 South America Gastro Esophageal Reflux Disease Drug and Devices Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Sales by Type (2017-2028)
11.2 Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Sales by Application (2017-2028)
11.3 Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Market Size by Country
11.3.1 Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Gastro Esophageal Reflux Disease Drug and Devices and Key Manufacturers
12.2 Manufacturing Costs Percentage of Gastro Esophageal Reflux Disease Drug and Devices
12.3 Gastro Esophageal Reflux Disease Drug and Devices Production Process
12.4 Gastro Esophageal Reflux Disease Drug and Devices Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Gastro Esophageal Reflux Disease Drug and Devices Typical Distributors
13.3 Gastro Esophageal Reflux Disease Drug and Devices Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Endogastric Solutions Basic Information, Manufacturing Base and Competitors
Table 4. Endogastric Solutions Major Business
Table 5. Endogastric Solutions Gastro Esophageal Reflux Disease Drug and Devices Product and Services
Table 6. Endogastric Solutions Gastro Esophageal Reflux Disease Drug and Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Medigus Basic Information, Manufacturing Base and Competitors
Table 8. Medigus Major Business
Table 9. Medigus Gastro Esophageal Reflux Disease Drug and Devices Product and Services
Table 10. Medigus Gastro Esophageal Reflux Disease Drug and Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Medtronic Basic Information, Manufacturing Base and Competitors
Table 12. Medtronic Major Business
Table 13. Medtronic Gastro Esophageal Reflux Disease Drug and Devices Product and Services
Table 14. Medtronic Gastro Esophageal Reflux Disease Drug and Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Carbon Medical technologies Basic Information, Manufacturing Base and Competitors
Table 16. Carbon Medical technologies Major Business
Table 17. Carbon Medical technologies Gastro Esophageal Reflux Disease Drug and Devices Product and Services
Table 18. Carbon Medical technologies Gastro Esophageal Reflux Disease Drug and Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 20. Johnson & Johnson Major Business
Table 21. Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Product and Services
Table 22. Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Global Gastro Esophageal Reflux Disease Drug and Devices Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 24. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 25. Market Position of Manufacturers in Gastro Esophageal Reflux Disease Drug and Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 26. Global Gastro Esophageal Reflux Disease Drug and Devices Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Gastro Esophageal Reflux Disease Drug and Devices Production Site of Key Manufacturer
Table 28. Gastro Esophageal Reflux Disease Drug and Devices New Entrant and Capacity Expansion Plans
Table 29. Gastro Esophageal Reflux Disease Drug and Devices Mergers & Acquisitions in the Past Five Years
Table 30. Global Gastro Esophageal Reflux Disease Drug and Devices Sales by Region (2017-2022) & (K Units)
Table 31. Global Gastro Esophageal Reflux Disease Drug and Devices Sales by Region (2023-2028) & (K Units)
Table 32. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue by Region (2017-2022) & (USD Million)
Table 33. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue by Region (2023-2028) & (USD Million)
Table 34. Global Gastro Esophageal Reflux Disease Drug and Devices Sales by Type (2017-2022) & (K Units)
Table 35. Global Gastro Esophageal Reflux Disease Drug and Devices Sales by Type (2023-2028) & (K Units)
Table 36. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue by Type (2017-2022) & (USD Million)
Table 37. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue by Type (2023-2028) & (USD Million)
Table 38. Global Gastro Esophageal Reflux Disease Drug and Devices Price by Type (2017-2022) & (USD/Unit)
Table 39. Global Gastro Esophageal Reflux Disease Drug and Devices Price by Type (2023-2028) & (USD/Unit)
Table 40. Global Gastro Esophageal Reflux Disease Drug and Devices Sales by Application (2017-2022) & (K Units)
Table 41. Global Gastro Esophageal Reflux Disease Drug and Devices Sales by Application (2023-2028) & (K Units)
Table 42. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue by Application (2017-2022) & (USD Million)
Table 43. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue by Application (2023-2028) & (USD Million)
Table 44. Global Gastro Esophageal Reflux Disease Drug and Devices Price by Application (2017-2022) & (USD/Unit)
Table 45. Global Gastro Esophageal Reflux Disease Drug and Devices Price by Application (2023-2028) & (USD/Unit)
Table 46. North America Gastro Esophageal Reflux Disease Drug and Devices Sales by Country (2017-2022) & (K Units)
Table 47. North America Gastro Esophageal Reflux Disease Drug and Devices Sales by Country (2023-2028) & (K Units)
Table 48. North America Gastro Esophageal Reflux Disease Drug and Devices Revenue by Country (2017-2022) & (USD Million)
Table 49. North America Gastro Esophageal Reflux Disease Drug and Devices Revenue by Country (2023-2028) & (USD Million)
Table 50. North America Gastro Esophageal Reflux Disease Drug and Devices Sales by Type (2017-2022) & (K Units)
Table 51. North America Gastro Esophageal Reflux Disease Drug and Devices Sales by Type (2023-2028) & (K Units)
Table 52. North America Gastro Esophageal Reflux Disease Drug and Devices Sales by Application (2017-2022) & (K Units)
Table 53. North America Gastro Esophageal Reflux Disease Drug and Devices Sales by Application (2023-2028) & (K Units)
Table 54. Europe Gastro Esophageal Reflux Disease Drug and Devices Sales by Country (2017-2022) & (K Units)
Table 55. Europe Gastro Esophageal Reflux Disease Drug and Devices Sales by Country (2023-2028) & (K Units)
Table 56. Europe Gastro Esophageal Reflux Disease Drug and Devices Revenue by Country (2017-2022) & (USD Million)
Table 57. Europe Gastro Esophageal Reflux Disease Drug and Devices Revenue by Country (2023-2028) & (USD Million)
Table 58. Europe Gastro Esophageal Reflux Disease Drug and Devices Sales by Type (2017-2022) & (K Units)
Table 59. Europe Gastro Esophageal Reflux Disease Drug and Devices Sales by Type (2023-2028) & (K Units)
Table 60. Europe Gastro Esophageal Reflux Disease Drug and Devices Sales by Application (2017-2022) & (K Units)
Table 61. Europe Gastro Esophageal Reflux Disease Drug and Devices Sales by Application (2023-2028) & (K Units)
Table 62. Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Sales by Region (2017-2022) & (K Units)
Table 63. Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Sales by Region (2023-2028) & (K Units)
Table 64. Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Revenue by Region (2017-2022) & (USD Million)
Table 65. Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Revenue by Region (2023-2028) & (USD Million)
Table 66. Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Sales by Type (2017-2022) & (K Units)
Table 67. Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Sales by Type (2023-2028) & (K Units)
Table 68. Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Sales by Application (2017-2022) & (K Units)
Table 69. Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Sales by Application (2023-2028) & (K Units)
Table 70. South America Gastro Esophageal Reflux Disease Drug and Devices Sales by Country (2017-2022) & (K Units)
Table 71. South America Gastro Esophageal Reflux Disease Drug and Devices Sales by Country (2023-2028) & (K Units)
Table 72. South America Gastro Esophageal Reflux Disease Drug and Devices Revenue by Country (2017-2022) & (USD Million)
Table 73. South America Gastro Esophageal Reflux Disease Drug and Devices Revenue by Country (2023-2028) & (USD Million)
Table 74. South America Gastro Esophageal Reflux Disease Drug and Devices Sales by Type (2017-2022) & (K Units)
Table 75. South America Gastro Esophageal Reflux Disease Drug and Devices Sales by Type (2023-2028) & (K Units)
Table 76. South America Gastro Esophageal Reflux Disease Drug and Devices Sales by Application (2017-2022) & (K Units)
Table 77. South America Gastro Esophageal Reflux Disease Drug and Devices Sales by Application (2023-2028) & (K Units)
Table 78. Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Sales by Region (2017-2022) & (K Units)
Table 79. Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Sales by Region (2023-2028) & (K Units)
Table 80. Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Revenue by Region (2017-2022) & (USD Million)
Table 81. Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Revenue by Region (2023-2028) & (USD Million)
Table 82. Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Sales by Type (2017-2022) & (K Units)
Table 83. Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Sales by Type (2023-2028) & (K Units)
Table 84. Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Sales by Application (2017-2022) & (K Units)
Table 85. Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Sales by Application (2023-2028) & (K Units)
Table 86. Gastro Esophageal Reflux Disease Drug and Devices Raw Material
Table 87. Key Manufacturers of Gastro Esophageal Reflux Disease Drug and Devices Raw Materials
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Gastro Esophageal Reflux Disease Drug and Devices Typical Distributors
Table 91. Gastro Esophageal Reflux Disease Drug and Devices Typical Customers
List of Figures
Figure 1. Gastro Esophageal Reflux Disease Drug and Devices Picture
Figure 2. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Type in 2021
Figure 3. Drugs
Figure 4. Devices
Figure 5. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Application in 2021
Figure 6. Drugs Treatment
Figure 7. Surgical Treatment
Figure 8. Minimally Invasive Treatment
Figure 9. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Gastro Esophageal Reflux Disease Drug and Devices Sales (2017-2028) & (K Units)
Figure 12. Global Gastro Esophageal Reflux Disease Drug and Devices Price (2017-2028) & (USD/Unit)
Figure 13. Global Gastro Esophageal Reflux Disease Drug and Devices Production Capacity (2017-2028) & (K Units)
Figure 14. Global Gastro Esophageal Reflux Disease Drug and Devices Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Gastro Esophageal Reflux Disease Drug and Devices Market Drivers
Figure 16. Gastro Esophageal Reflux Disease Drug and Devices Market Restraints
Figure 17. Gastro Esophageal Reflux Disease Drug and Devices Market Trends
Figure 18. Global Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Manufacturer in 2021
Figure 19. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Manufacturer in 2021
Figure 20. Gastro Esophageal Reflux Disease Drug and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Gastro Esophageal Reflux Disease Drug and Devices Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Gastro Esophageal Reflux Disease Drug and Devices Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Region (2017-2028)
Figure 24. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Region (2017-2028)
Figure 25. North America Gastro Esophageal Reflux Disease Drug and Devices Revenue (2017-2028) & (USD Million)
Figure 26. Europe Gastro Esophageal Reflux Disease Drug and Devices Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Revenue (2017-2028) & (USD Million)
Figure 28. South America Gastro Esophageal Reflux Disease Drug and Devices Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Revenue (2017-2028) & (USD Million)
Figure 30. Global Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Type (2017-2028)
Figure 31. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Type (2017-2028)
Figure 32. Global Gastro Esophageal Reflux Disease Drug and Devices Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Application (2017-2028)
Figure 34. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Application (2017-2028)
Figure 35. Global Gastro Esophageal Reflux Disease Drug and Devices Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Type (2017-2028)
Figure 37. North America Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Application (2017-2028)
Figure 38. North America Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Country (2017-2028)
Figure 39. North America Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Country (2017-2028)
Figure 40. United States Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Type (2017-2028)
Figure 44. Europe Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Application (2017-2028)
Figure 45. Europe Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Country (2017-2028)
Figure 46. Europe Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Country (2017-2028)
Figure 47. Germany Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Region (2017-2028)
Figure 56. China Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Type (2017-2028)
Figure 63. South America Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Application (2017-2028)
Figure 64. South America Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Country (2017-2028)
Figure 65. South America Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Gastro Esophageal Reflux Disease Drug and Devices in 2021
Figure 77. Manufacturing Process Analysis of Gastro Esophageal Reflux Disease Drug and Devices
Figure 78. Gastro Esophageal Reflux Disease Drug and Devices Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source